[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100568412":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":23,"centralContacts":29,"locations":23,"responsibleParty":35,"collaborators":23,"id":39,"slug":23,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":40,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":23,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":60,"whyStopped":23,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":23},{"fullName":5,"class":6},"The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"study group","EXPERIMENTAL","The study group, comprising 30 individuals, received a combination therapy of non-invasive auricular acupoint stimulation and prucapride",[13],"Other: Auricular Acupoint Stimulation +prucapride",{"label":15,"type":6,"description":16,"interventionNames":17},"control group","also consisting of 30 patients, was administered prucapride as a monotherapy.",[18],"Drug: prucapride",[20,24],{"type":6,"name":21,"description":11,"armGroupLabels":22,"otherNames":23},"Auricular Acupoint Stimulation +prucapride",[9],null,{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":23},"DRUG","prucapride","was administered prucapride as a monotherapy",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":23,"email":34},"Heng Deng, Dr.","CONTACT","+8613335510159","tangkun23@outlook.com",{"type":36,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":23,"oldOrganization":23},"PRINCIPAL_INVESTIGATOR","Heng Deng","The Second hospital affiliated Anhui University of Chinese Medicine","100568412",false,"NCT06680882","The Effect of Non-invasive Auricular Acupoint Stimulation on Slow Transmission Constipation","The Second Hospital Affiliated Anhui University of Chinese Medicine","AAS","Inclusion Criteria: ① Conformity to the diagnostic benchmarks for STC as delineated in the Rome IV criteria; ② Absence of ingestion of any medication influencing gastrointestinal motility within the preceding three months; ③ Provision of informed consent after a comprehensive understanding of the study's objectives; ④ An age range of 40 to 75 years.\n\n\\-\n\nExclusion Criteria: ① Withdrawal from the therapeutic regimen; ② Auricle or ear canal pathologies; ③ Organic defecation disorder; ④ Pregnant or lactating.\n\n\\-","ALL","40 Years","75 Years",{"count":50,"type":51},60,"ESTIMATED","INTERVENTIONAL",[54],"PHASE2","Objective To examine the therapeutic effect and safety of non-invasive auricular acupoint stimulation application on patients with slow transmission constipation.\n\nMethods In a randomized clinical trial, 60 patients diagnosed with slow transit constipation (STC), ranging in age from 40 to 75 years, were allocated into two distinct cohorts: a study group and a control group. The study group, comprising 30 individuals, received a combination therapy of non-invasive auricular acupoint stimulation and prucapride, while the control group, also consisting of 30 patients, was administered prucapride as a monotherapy. To assess the efficacy of the interventions, various parameters were monitored, including serum levels of Neuropeptide Y (NPY), nitric oxide (NO), fecal water content, and gastrointestinal (GI) transit. The comparative therapeutic outcomes were determined by calculating symptom scores.",[57],"Slow Transmission Constipation",[59],"slow transmission constipation","NOT_YET_RECRUITING","2024-11-06",{"date":63,"type":64},"2024-11-08","ACTUAL",{"date":66,"type":51},"2024-11-07",{"date":68,"type":51},"2025-11-01",{"name":5,"class":6}]